While Dr. Moro is at the helm and ultimately will decide where we are headed, here is how I see things.

1. The stock price is what it is(pure and simple)

Dr. Moro has stated in the past that it makes no sense how this company is priced. I personally bought in about 4 or 5 years ago when this stock was at about 25 cents. All the company had was a simple stain of Recaf that could be placed on a slide to stick under a microscope to see if a physical scraping of a tumor / biopsy was cancerous or not. They were only working on a prototype test that had low radioactivity that might prove to test a blood sample.

The stock eventually shot up to around $4 per share almost overnight when it was thought that the company had FDA approval on the staining agent.

The stock price crept lower until Abbott Labs signed a licensing agreement with Biocurex. http://goliath.ecnext.com/coms2/gi_0...

Regardless of what our Bashers say about Abbott...Abbott did their Due Dilligence on Recaf and were obviously pleased with the outcome. They made payments to Biocurex and also included Recaf into a patent for a panel of Biomarkers for the detection of Lung Cancer.

During this two or so years we waited on Abbott to commercialize Recaf, a lot of events transpired.

Recaf evolved from a low radioactive test that was not advantageous for high throughput machines into a new format that contained no radioactivity called the (colorimetric) version . http://www.globenewswire.com/newsroo...

Abbott ran into some sort of internal Company difficulties. They planned to sell the diagnostic unit of Abbott to General Electric for around 8 billion dollars. Infact Biocurex signed a transfer letter to include Biocurex in the deal. http://www.redorbit.com/news/health/...

Well the deal fell through between Abbott and GE. It was at this point that Abbott began reducing its staff in the diagnostic area (to save money)

It is believed that Recaf got caught up in the Abbott downsizing. No one knows if Recaf is in short term limbo with Abbott or if they are secretly working with it or if they will never work with it. The truth is Abbott has not said much of anything concerning the future of Recaf other than it works awesomely. http://www.redorbit.com/news/health/...

We then saw where Biocurex signed an agreement with Inverness. http://www.reuters.com/article/press...

Inverness has paid Biocurex 1 million to date as they progress with there commercialization of Recaf. We really don't know what Inverness is making out of Recaf but the good Doctor says we are getting close to commercialization.

Also . Recaf now has a simple inexpensive new format (s) of Elisa and the simple pregnancy type quick test. They also have produced a saliva type test that looks to be pretty awesome.

The Bottom Line.

1. Yes the stock price went from 25 cents to $4 dollars and back down to a current 14 cents.

2. The technology has transformed into an awesome blood and or saliva test that could be used right now today to give an accurate reading to determine if a person does or does not have cancer (and yes...better than any other test on the market)

3. We do not have FDA approval but are hopefull that Inverness or Abbott or ? will progress with trials to achieve FDA approval.

4. Recaf technology has the proven ability to be injected into a human to show exactly where cancer is present. (Not FDA Approved though)

5. Recaf has cured mice of cancer. Killed the tumors and left the mice healthy.

We are now in a stage where we have a great technology that works. We have large companies interested in Recaf. We also have an economy (worldwide) that is financially stressed to the max.

Short of payments that are due to a company that provided a couple of million dollars to Biocurex, the company can sit in a state of hybernation until more funds are available. (This is not prefered but is possible)

Keep in mind that the company that is owed the money cannot do squat with the company without Dr. Moro. Dr. Moro stated he is not interested in the sale of the company.

We are awaiting news from our China operation and that of Inverness and ???Abbott???. Also there may be another license in progress.

It is frustrating to wait this out for stockholders and employees etc.

Selling now would imo not be worth the 14 cent price. IMO we will either see some fruitfull news that will advance the stock considerably or we will drift in these penny prices for an undetermined amount of time.

I do not see the company going into Bankruptcy. I do not see the funding agent taking control of the company.

Gold seeker will have a field day saying he was correct in his bashing however which stock on any market could he have been incorrect on? They are all in the tank right now.

I am holding and will continue to hold. I will either be a rich man from this stock or will die from Cancer one of these years waiting on the FDA to approve a real test for the detection of cancer.